DIGIRAD CORPORATION (NASDAQ:DRAD) Files An 8-K Results of Operations and Financial ConditionItem 2.02. Results of Operations and Financial Condition
DIGIRAD CORPORATION (NASDAQ:DRAD) Files An 8-K Results of Operations and Financial Condition
On April 28, 2017, Digirad Corporation issued a press release announcing financial results for the three months ended March 31, 2017. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
Item 9.01. Financial Statements and Exhibits
(a) Financial statements:
>>>>>>>>>>>>None
(b) Pro forma financial information:
>>>>>>>>>>>>None
(c) Shell company transactions:
>>>>>>>>>>>>None
(d) Exhibits:
99.1 Press Release of Digirad Corporation dated April 28, 2017
99.2 Information Related to the Use of Non-GAAP Financial Measures
About DIGIRAD CORPORATION (NASDAQ:DRAD)
Digirad Corporation is a provider of diagnostic solutions. The Company’s business is organized into two segments: Diagnostic Services and Diagnostic Imaging. The Company provides in-office nuclear cardiology and ultrasound imaging services. It also provides cardiac event monitoring services to physician practices, hospitals and imaging centers through its Diagnostic Services business segment. The Company sells solid-state gamma cameras for nuclear cardiology and general nuclear medicine applications, as well as provides service on the products it sells through its Diagnostic Imaging business segment. Diagnostic Services also offers remote cardiac event monitoring services, which include provision of a monitor, remote monitoring by registered nurses and monitoring support for its patients and physician customers. Its nuclear cameras feature detectors based on solid-state technology. Its cameras are used in hospitals, imaging centers, physician offices, and by mobile service providers. DIGIRAD CORPORATION (NASDAQ:DRAD) Recent Trading Information
DIGIRAD CORPORATION (NASDAQ:DRAD) closed its last trading session down -0.05 at 5.15 with 76,298 shares trading hands.
Digirad Corporation is a provider of diagnostic solutions. The Company’s business is organized into two segments: Diagnostic Services and Diagnostic Imaging. The Company provides in-office nuclear cardiology and ultrasound imaging services. It also provides cardiac event monitoring services to physician practices, hospitals and imaging centers through its Diagnostic Services business segment. The Company sells solid-state gamma cameras for nuclear cardiology and general nuclear medicine applications, as well as provides service on the products it sells through its Diagnostic Imaging business segment. Diagnostic Services also offers remote cardiac event monitoring services, which include provision of a monitor, remote monitoring by registered nurses and monitoring support for its patients and physician customers. Its nuclear cameras feature detectors based on solid-state technology. Its cameras are used in hospitals, imaging centers, physician offices, and by mobile service providers. DIGIRAD CORPORATION (NASDAQ:DRAD) Recent Trading Information
DIGIRAD CORPORATION (NASDAQ:DRAD) closed its last trading session down -0.05 at 5.15 with 76,298 shares trading hands.
